GamaMabs Pharma raised €3.1M in a Series A round in Sep 2013. The company is based in Toulouse, France. Investors in the round: Bpifrance. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €3.1M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
